GSK plc Proceeds From Sales Of Investments Accounted For Using Equity Method
GSK plc (GLAXF) reported Proceeds From Sales Of Investments Accounted For Using Equity Method of GBP 0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod · last filed 2026-03-06
| Period end | Proceeds From Sales Of Investments Accounted For Using Equity Method 12 month |
|---|---|
| 2025-12-31 | 0.00 GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | 0.00 GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | 1.00M GBP 20-F · filed 2026-03-06 |
| 2022-12-31 | 0.00 GBP 20-F · filed 2025-03-03 |